Latvian Oncology Center

Riga

0 studies enrolling now · 1 studies all time

What they study most

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) — Running, not enrolling